In humans, FETUB levels were significantly higher in normal prostate cell lines compared to prostate cancer (PC) cells, and FETUB overexpression inhibited PC cell proliferation, migration, and invasion by inhibiting the PI3K/AKT signaling pathway and inducing apoptosis [130]. The gene discussed is FETUB; the disease is pachyonychia congenita.